Credit Agricole’s Juno Therapeutics, Inc. JUNO Stock Holding History

Credit Agricole’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-30,800	Closed	-$1.38M	–	1340
2017 Q3	$1.38M	Buy	+30,800	New	+$1.05M	﹤0.01%	1024
2017 Q1	–	Sell	-18,180	Closed	-$343K	–	1736
2016 Q4	$343K	Buy	+18,180	New	+$445K	﹤0.01%	1271
2015 Q1	–	Sell	-5,200	Closed	-$275K	–	1582
2014 Q4	$275K	Buy	+5,200	New	+$233K	﹤0.01%	1355

Other funds holding JUNO

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Credit Agricole's JUNO Position: Q4 2017 in Review

Credit Agricole sold out of Juno Therapeutics, Inc. (JUNO) in Q4 2017, closing a stake of 30,800 shares — an estimated $1.38M sold.

Credit Agricole first reported a position in JUNO in Q4 2014 and held it in 3 quarters. The position peaked at $1.38M in Q3 2017. 237 funds tracked by Wall St. Rank hold JUNO as of Q4 2017.

Credit Agricole reported no remaining Juno Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Credit Agricole sold 30,800 Juno Therapeutics, Inc. shares in Q4 2017, an estimated $1.38M.
Credit Agricole first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 3 quarters.
Credit Agricole's Juno Therapeutics, Inc. position peaked at $1.38M in Q3 2017.
237 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2017.

Based on Credit Agricole's 13F filing for Q4 2017, filed 13 Feb 2018.